evidence of good faith social equity efforts" in monthly reports.
On Thursday, Cannabis Regulatory Commission Diversity and Inclusion Director Wesley McWhite III said operators had "constantly been told to put. The issue seemed to encapsulate an issue the state's cannabis regulators have complained about since the commission was established: Companies are required to make regular reports detailing how they're trying to tackle certain issues in the cannabis industry, such as tackling social equity and continuing to prioritize medical marijuana patients.Īt numerous public commission meetings throughout the commission's two-year history, commissioners have offered sternly-worded reminders that, under state law, license holders are required to make regular reports to and respond promptly to requests for information by the commission. The remaining five employees were not due to job performance or other issues, he said. Thirty-five of the 40 employees working at the Bellmawr cultivation center were offered new jobs, he said. "The nature and reason for those changes was really multi-faceted, including changes in the cannabis market and the demand for that, the fact that our Winslow facility is a state-of-the-art facility producing a high-quality flower at a very efficient rate and all of the considerations that go into managing a process and trying to mitigate costs where we can to keep prices down," Shorris said. But the decision was made due to demand in the cannabis market that the newer Winslow facility could meet. James Shorris, Curaleaf's chief compliance officer, said he wasn't sure of the exact timing when asked whether Curaleaf was already contemplating the move when it filed its renewal application. NJ legal weed: Home grow is a no-go, but advocates push to change that
"I think it's important for the board and the staff at large to have proper insight and timely notice of major changes to a facility's operations."
"I am concerned about the layoff announcement that was made last month before any information was provided to the commission about any changes Curaleaf was going to make," said Cannabis Regulatory Commission chair Dianna Houenou, who also abstained.
0 kommentar(er)
